Brigit Biofarmaka Teknologi Tbk. vs Pollux Hotels Group Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 50.3K 24h volume), while Pollux Hotels Group Tbk. trades at Rp750 (market cap 1.5T, 5.1K 24h volume). The key difference: Pollux Hotels Group Tbk. is far larger — about 9.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (50.3K versus 5.1K). Which is the better fit depends on your goals.
| OBAT | POLI | |
|---|---|---|
Market Cap | 164.65B | 1.5T |
Volume | 50.3K | 5.1K |
Lot | 503 | 51 |
Turnover | 12.13M | 3.76M |
Average Price | 241.18 | 736.76 |
Value | 12.13M | 3.76M |
Indicative Equilibrium Price | 238 | 745 |
Indicative Equilibrium Volume | 100 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Pollux Investasi Internasional, Tbk (formerly PT Royal Royce Properties) (the "Company" or "Parent Company") established on Jakarta based on the Notarial Deed No. 126 dated August 27, 2009 by Sutjipto, S.H., M.Kn., a notary in Jakarta.
Read more on POLI →